From Wednesday November 20th to Sunday November 24th, there will be a delay in the processing of support requests. This includes system generated requests (project changes, production moves, API requests, etc) as well as questions sent to redcap@uchicago.edu. Requests may take up to 48 hours to process. If your request is urgent, please contact REDCap Support. Thank you for your understanding and patience.
Saturday 11/9/24 7:00AM CST: REDCap is back online and available for use. Please view the new features and functionality here. We sincerely apologize for the inconvenience this outage caused and appreciate your patience while we restored service. Please contact REDCap Support with any further questions. Thank you.
Event: REDCap Scheduled Downtime and Upgrade
Date/Time: Wednesday, November 6th, 2024, 5PM-7PM CST
Website: https://redcap.uchicago.edu
Reason: The REDCap application will be upgraded to a newer version of the software.
Who Is Affected: All University of Chicago REDCap users, including non-UChicago external collaborators, mobile app users, API users, survey participants.
Impact: REDCap will be unavailable during this downtime. Unavailability is defined as:
- Survey emails and Alerts & Notifications will be halted until the upgrade is complete.
- Survey links will be inaccessible and will display a ‘REDCap is offline’ message when clicked on.
- API activity will be halted until the upgrade is complete.
- Mobile app users are strongly encouraged to sync any data on their devices back to their REDCap project before the upgrade begins. Although not recommended, offline data collection may continue in the app during the upgrade, however the online sync process will not be available until the upgrade is complete.
Updates: A message will be posted on the REDCap login page confirming the upgrade’s completion, along with details of the newest features and improvements.
Questions? Please email REDCap Support.
REDCap has been successfully upgraded to version LTS 14.5.15. Details of the newest features and improvements can be found here. We hope you enjoy the newest functionality. Please contact REDCap Support with any questions.
The following is a summary of improvements being made on Wednesday, October 16th, 2024 for the handling of outgoing REDCap email messages. There will be no application downtime needed for these improvements, as they will happen on REDCap’s back-end email message handling setup.
All University and UCMC REDCap users including external collaborators who send email messages within REDCap will be affected. This includes email messages sent as part of:
- Survey Invitations (both manual and automated, and reminders)
- Alerts & Notifications
- Survey Confirmations
The need for these improvements comes from email providers blocking emails whose ‘From:’ address does not match the domain name of the REDCap server (e.g., sending an email from user@uchospitals.edu from the server https://redcap.uchicago.edu). The following email address domains are now permitted to send email messages from our REDCap server, therefore, no blocked messages should occur going forward:
- uchicago.edu
- uchospitals.edu
- uchicagomedicine.org
- bsd.uchicago.edu
- (department).bsd.uchicago.edu
- dacc.uchicago.edu
- radonc.uchicago.edu
- ingalls.org
- chapinhall.org
All other email address domains (not in the list above) will have no-reply-redcap@uchicago.edu as the ‘From:’ address (although the message will still have the ‘Reply-To’ value as the sender). This piece will mostly affect, for example, multi-site studies where external collaborators (e.g., Rush, Mayo, etc) are sending email messages from within UChicago REDCap projects.
Lastly, as a general rule to improve email delivery to inboxes, please refrain from sending email messages from external email accounts (e.g., Gmail, Yahoo, etc.) and instead always use an institutional email address.
Questions? Issues? Please email REDCap Support.
Tuesday, June 4th 5:00PM CST – The Department of Neurology at The University of Chicago Medical Center has a great history and tradition, having made significant contributions to neurological training, clinical care, and the basic understanding of neurological disease. The Healthy Aging & Alzheimer’s Research Care (HAARC) Center, is a new multidisciplinary center at the University of Chicago focused on implementing research on aging, Alzheimer’s and related dementia research focused on optimizing knowledge, care, interventions, and quality of life. The HAARC Center is seeking a Data Analyst to support data management across research projects. Click HERE to access the link to the posting. This is a CRI courtesy posting for HAARC; please contact haarcresearch@uchicago.edu with any further questions.
Launching a Tool to Improve Data Access – A transformative collaboration will build a unified data repository to provide faster access to data and propel advancements in healthcare delivery, research, and operational efficiency at the University of Chicago and UChicago Medicine health system. The Biological Sciences Division and UChicago Medicine, in partnership with the health system Chief Medical Officer’s team, the Center for Research Informatics, and Information Services teams, are at the forefront of this initiative, which will leverage self-service tools and personalized support to dramatically expand access to data. Read press release and read more here.
The Office for Human Research Protections (OHRP) has created and posted a brand new interactive informed consent training program entitled “Participant-Centered Informed Consent Training”. It consists of 6 modules and is intended to provide training to help design, create, use, and review consent forms or templates.
This training is intended to provide education that will aid in providing research participants with understandable content in the consent form document so that the participant can better understand the research taking place and how their decision on whether to participate could impact them personally. OHRP notes in the training modules that when participants understand the research and potential personal impact, it promotes trust and engagement in research. It is important to note that this training is not intended to be a comprehensive overview of the regulatory requirements of informed consent.
OHRP describes the intended audience of this training to be anyone from an investigator or research coordinator to an IRB reviewer or even someone designing electronic consent forms for an online platform. The training is available now on OHRP’s website. OHRP will also be conducting a demonstration of this new interactive training program on February 23, 2024, at 12:00 PM EST via this Zoom link.
Original News Source: University of Chicago – Office of Clinical Research, February 2024 Newsletter (Volume 13, Issue 8)
The FDA recently issued a draft guidance entitled “Collection of Race and Ethnicity Data in Clinical Trials and Clinical Studies for FDA-Regulated Medical Products”. This guidance document would replace the current guidance document from 2016 entitled “Collection of Race and Ethnicity Data in Clinical Trials”. This new guidance document is meant to set FDA expectations and standards for collecting race and ethnicity data in submissions. Standardizing language and setting expectations for race and ethnicity data in this guidance document ensures that this data is consistently collected and reported to the FDA.
The FDA notes in this guidance document that collecting and reporting race and ethnicity data using standardized terminology is critically important in identifying population-specific signals, which while uncommon, have been observed in racially and ethnically diverse populations.
The draft guidance is proposing a two-question system for documenting race and ethnicity data in Clinical Trials and Clinical Studies using first “Are you Hispanic/Latino or not Hispanic/not Latino?” followed by “What is your race?”. They recommend the following options at a minimum for a response to this question regarding race: American Indian or Alaska Native, Asian, Black or African American, Native Hawaiian or Other Pacific Islander, and White. They list OMB Policy Directive 15 recommended language regarding ethnicity and race question responses, noting that nonwhite is not demographic data that can be reported to the federal government. The FDA guidance recommends following best practices by having participants self-report their ethnicity and race rather than it being assigned by study team members, as well as instructing the participants to mark one or more race if needed in their self-report.
It is noted in the draft guidance that the FDA does recognize that racial and ethnicity data and recommendations provided in this guidance are focused in United States and may not be applicable to clinical trials that occur outside of the US and if more granularity is needed to follow the 2011 HHS Implementation Guidance on Data Collection Standards for Race, Ethnicity, Sex, Primary Language, and Disability Status.
The FDA also recommends in this guidance document that Investigation New Drug (IND), New Drug Applications (NDA), and Biologics License Applications (BLA) use the race and ethnicity guidelines laid out within this proposed guidance document to tabulate demographic data for new clinical trials and clinical studies.
This guidance document is open to comments from the public until April 29, 2024.
Original News Source: University of Chicago – Office of Clinical Research, February 2024 Newsletter (Volume 13, Issue 8)
January 18, 2024, 10:00am – If you are unable to access REDCap because of a 403 error message, please try the following: clear your browser’s cache, restart your browser, and log into vpn https://vpn.uchicago.edu, and then log into REDCap at https://redcap.uchicago.edu/. If you are still unable to access the page, please reach out to us at redcap@uchicago.edu. Thank you for your patience and apologies again for any inconvenience. Please continue to follow this page for any further updates.
January 17, 2024, 12:00pm – We are currently experiencing a REDCap outage. The team is working to identify the cause and is working on restoring service. At this time, we do not have an estimate on when service will be restored. We apologize for the inconvenience. Please follow this page for all updates. Email redcap@uchicago.edu with any further questions.
Details: This is to inform our UChicago REDCap user community of a change to our REDCap Support email address. On December 1st, the new email address will change to redcap@uchicago.edu. Please use the new email address for your support requests or inquiries. Support requests generated within REDCap (production moves, project changes, etc.) will automatically use the new email address. The ‘Contact REDCap Administrator’ blue button in the lower left corner of your projects will also use the new address. Please kindly refrain from directly emailing our REDCap Administrator’s Outlook email address, as our goal is to offer a single point of contact with redcap@uchicago.edu allowing us to improve service delivery, streamline workflows, and measure metrics.
Who Is Affected: All University of Chicago REDCap users (including external collaborators)
A note on password help: Passwords are not managed by REDCap Support. For BSDAD or UCHAD password help, please visit the UCMIT Service Now Portal or for external collaborator account password help, please email BSDIS at bsdis@bsd.uchicago.edu.
Questions, comments, feedback? Please contact us via our REDCap Inbox.
Thank you for your support and continued use of REDCap!
(Post Date: 11/9/23)
